Arena Pharmaceuticals Inc ARNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/09/21 EDT
66.01quote price arrow down-0.28 (-0.42%)
Volume
7,174
Close
66.29quote price arrow down-0.20 (-0.30%)
Volume
381,970
52 week range
44.79 - 90.19

...

Loading . . .
  • Open66.15
  • Day High67.61
  • Day Low66.04
  • Prev Close66.49
  • 52 Week High90.19
  • 52 Week High Date11/04/20
  • 52 Week Low44.79
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap3.999B
  • Shares Out60.33M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta0.53
  • YTD % Change-13.72

KEY STATS

  • Open66.15
  • Day High67.61
  • Day Low66.04
  • Prev Close66.49
  • 52 Week High90.19
  • 52 Week High Date11/04/20
  • 52 Week Low44.79
  • 52 Week Low Date05/14/20
  • Market Cap3.999B
  • Shares Out60.33M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta0.53
  • YTD % Change-13.72

RATIOS/PROFITABILITY

  • EPS (TTM)-7.39
  • P/E (TTM)-8.97
  • Fwd P/E (NTM)-7.72
  • EBITDA (MRQ)-422.781M
  • ROE (MRQ)-37.62%
  • Revenue (MRQ)320,000.00
  • Gross Margin (MRQ)35.70%
  • Net Margin (MRQ)-126,875.90%
  • Debt To Equity (MRQ)4.22%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Arena Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the treatment of pain associated with Crohn's disease, and ralinepag (APD811) in Phase II evaluation for pulmonary arterial hypertension (PAH). The...
Garry Neil M.D.
Non-Executive Chairman
Amit Munshi
President
Laurie Stelzer CPA
Chief Financial Officer
Robert Lisicki
Executive Vice President
Joan Schmidt J.D.
Executive Vice President
Address
6154 Nancy Ridge Dr
San Diego, CA
92121-3223
United States

Top Peers

SYMBOLLASTCHG%CHG
RETA
Reata Pharmaceuticals Inc
88.42-6.45-6.80%
BHVN
Biohaven Pharmaceutical Holding Company Ltd
69.39-1.53-2.16%
BEAM
Beam Therapeutics Inc
70.23-4.59-6.13%
TPTX
Turning Point Therapeutics Inc
78.95-3.11-3.79%
KRTX
Karuna Therapeutics Inc
116.91-1.03-0.87%